Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Sanofi 13.284, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
Sanofi vs CSL: Revenue Comparison
Sanofi (SNY) and CSL (CSL.AX) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $7.3B for CSL. Sanofi leads on revenue.
Sanofi's gross margin is 75.5% versus 44.4% for CSL. Sanofi's net margin is 2.8% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, CSL.| Metric | Sanofi | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $13.28B | $7.30B |
| Cost of Revenue | $3.26B | $4.06B |
| Gross Profit | $10.03B | $3.24B |
| Operating Income | $2.58B | $1.39B |
| Net Income | $370.00M | $-2.94B |
| R&D Expense | $2.41B | $614.00M |
| Earnings Per Share | $0.15 | -$6.14 |
| Gross Margin | 75.5% | 44.4% |
| Operating Margin | 19.4% | 19.0% |
| Net Profit Margin | 2.8% | -40.2% |
| Free Cash Flow | $4.22B | $1.76B |
| Cumulative Free Cash Flow | $51.81B | $21.56B |
| Operating Cash Flow | $5.85B | $2.09B |
| Cash & Equivalents | $6.86B | $1.51B |